Changes for page Neurodiagnoses

Last modified by manuelmenendez on 2025/03/03 22:46
From version 26.1
edited by manuelmenendez
on 2025/01/29 18:48
Change comment: There is no comment for this version
To version 24.1
edited by manuelmenendez
on 2025/01/29 18:46
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -23,6 +23,10 @@
23 23  * **Axis 2**: Molecular Markers (biomarkers).
24 24  * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
25 25  
26 +
27 +[[For instance, neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
28 +
29 +
26 26  This methodology enables:
27 27  
28 28  * Greater precision in diagnosis.
... ... @@ -33,8 +33,6 @@
33 33  
34 34  There have been described these 3 diagnostic axes:
35 35  
36 -[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
37 -
38 38  * (((
39 39  **Axis 1: Etiology**
40 40  
... ... @@ -82,8 +82,6 @@
82 82  )))
83 83  
84 84  
85 -
86 -
87 87  (% class="col-xs-12 col-sm-4" %)
88 88  (((
89 89  {{box title="**Contents**"}}